Company Badge
USPTO Data Jan 1 1976 - Oct 6 2026
36 Patents
#7 in Abingdon
#503 in United Kingdom
#18,730 in the World
Syntaxin Limited
Forward Citations = 386
26 inventors:
Syntaxin Limited
% Expired Patents = 41.7
CIPO Patents = 2
EPO Patents = 5
Forward Citations = 386
Loading Chart...
Loading Chart...
26 inventors (with patents filed for the assignee):
Keith Foster (30 out of 49 patents)
John Andrew Chaddock (27 out of 41 patents)
Philip Marks (18 out of 26 patents)
4. Patrick Stancombe (17 out of 20 patents)
5. Lance Steward (13 out of 102 patents)
6. Joseph Francis (13 out of 51 patents)
7. Kei Roger Aoki (12 out of 126 patents)
8. Clifford Charles Shone (10 out of 29 patents)
9. Conrad Padraig Quinn (9 out of 24 patents)
10. Charles Penn (7 out of 9 patents)
11. Jonathan Wayne (6 out of 8 patents)
12. John Mark Sutton (4 out of 9 patents)
13. J Mark Sutton (4 out of 10 patents)
14. Lyndsey Durose (4 out of 4 patents)
15. Michael John Duggan (4 out of 8 patents)
Core Competencies:
Non-Cytotoxic Protein Conjugates
Fusion Proteins
Recombinant Toxin Fragments
Clostridial Toxin Derivatives
Targeting Nerve Cells
Pain Treatment
Mucus Hypersecretion
Therapeutic Agent Delivery
Neuroendocrine Diseases
EGF Muteins
Analgesics
Superoxide Dismutase
36 patents:
Company Overview
Syntaxin Limited, based in Abingdon, UK, specializes in the development of innovative biopharmaceuticals, focusing on the modulation of protein interactions. The company is dedicated to advancing therapeutic solutions through its proprietary technologies, particularly in the fields of neuroscience and metabolic disorders. By leveraging its expertise in protein engineering and drug delivery systems, Syntaxin aims to address unmet medical needs and improve patient outcomes through targeted therapies.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Syntaxin Limited. Retrieved from https://idiyas.com/company/syntaxin
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]